Download PDF
Thromb Haemost 1995; 74(02): 799-800
DOI: 10.1055/s-0038-1649819
Letter to the Editor
Schattauer GmbH Stuttgart

Lipoprotein (a) and Anticardiolipin Antibodies as Risk Factors for Vascular Disease in Rheumatoid Arthritis

B Seriolo
Division of Rheumatology, University of Genova, Genova, Italy
,
S Accardo
Division of Rheumatology, University of Genova, Genova, Italy
,
D Fasciolo
Division of Rheumatology, University of Genova, Genova, Italy
,
A Sulli
Division of Rheumatology, University of Genova, Genova, Italy
,
S Bertolini
1   Atherosclerosis Prevention Centre, Department of Internal Medicine, University of Genova, Genova, Italy
,
M Cutolo
Division of Rheumatology, University of Genova, Genova, Italy
› Author Affiliations
Further Information

Publication History

Received 15 November 1994

Accepted after resubmission 20 February 1995

Publication Date:
06 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Rankinen T, Välsänen S, Mercuri M, Raurama R. Apolipoprotein (a), fibrinopeptide A and carotid atherosclerosis in middle-aged men. Thromb Haemost 1994; 72: 563-566
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Yamazaki M, Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Aoshima K, Ikeda T, Matsuda T. Plasma levels of lipoprotein (a) are elevated in patients with antiphospholipid antibody syndrome. Thromb Haemost 1994; 71: 424-427
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Seriolo B, Accardo S, Cutolo M. von Willebrand factor and vascular injury in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 550
    PubMedGoogle Scholar
  • 4 Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-344
    CrossrefPubMedGoogle Scholar
  • 5 Seriolo B, Cutolo M, Fasciolo D, Accardo S. Anticardiolipin antibodies in rheumatoid arthritis. Ann Rheum Diss 1992; 51: 1100
    PubMedGoogle Scholar
  • 6 Fort JG, Cowchock FS, Abruzzo JL, Smith JB. Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 1987; 30: 752-760
    CrossrefPubMedGoogle Scholar
  • 7 Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantification of results. Clin Exp Immunol 1985; 62: 738-745
    PubMedGoogle Scholar
  • 8 Seriolo B, Cutolo M, Fasciolo D, Accardo S. Lipoprotein(a) and anticardiolipin antibody concentration in rheumatoid arthritis. Arthritis Rheum 1994; 37: 248
    CrossrefPubMedGoogle Scholar
  • 9 Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 2540-2544
    PubMedGoogle Scholar
  • 10 Edelberg JM, Pizzo SV. Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner. Blood Coagulat Fibrinol 1991; 2: 759-764
    PubMedGoogle Scholar
  • 11 Harris NN, Asherson RA, Gharavi AE, Morgan SH, Derue GD, Hughes GRV. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol 1985; 59: 227-230
    CrossrefPubMedGoogle Scholar